José Procopio Procópio Senna

Dr. José Procopio Procópio Senna

orcid

Biography

Graduated in Pharmacy from the Federal University of Rio Grande do Sul (1987), a Master's degree in Microbiology, Pathogenesis of Microorganisms and Agents Antinfectieux - Université Paris Sud (1995) and PhD in Cellular and Molecular Biology from the Federal University of Rio Grande do Sul 2001), pos doc Institut Pasteur, Unité des Agents Antibactériens 2003. He is currently specialist in public health at the Institute of Technology in Immunobiologics - BioManguinhos - Fiocruz. He has experience in the area of Immunobiologicals, with emphasis on microbiology, working mainly on the following topics: Multidrug-resistant bacteria, development of passive immunotherapy - therapeutic monoclonal antibodies, vaccines and aptamers for the treatment, identification and prophylaxis of multidrug-resistant bacteria.

Affiliations

No affiliation has been shared yet.

Honors and Awards

honor

2023 Honorable Mention -

Institute of Technology In Immunobiologicals - BioManguinhos FIOCRUZ

2023 Honorable Mention - work ANTI-PBP2A MONOCLONAL ANTIBODY FAB-LIKE FRAGMENT RADIOLABELING WITH TECHNETIUM-99M FOR IN SITU DIAGNOSIS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA), ISI-2023 - Institute of Technology in Immunobiologicals - BioManguinhos - FIOCRUZ

honor

Poster Winner

Pep Talk 2023

2023 Poster Winner - Best work, Pep Talk - 2023 - The protein science and production week

honor

Collections of Antibiotic Resistance PLOS

PLOS

2020 Inclusion of the work Monoclonal antibody anti-PBP2a protects mice against MRSA infections in Collections Antibiotic Resistance PLOS, PLOS

honor

Award best poster

Institute of Technology in Immunobiologicals FIOCRUZ

2011 Award Poster II International Symposium on Immunobiologicals, Bio-Manguinhos Institute of Technology in Immunobiologicals FIOCRUZ

honor

Edward Jenner Prize

Global Congress on Vaccines

2008 Edward Jenner Prize, Wyeth - 2nd Global Congress on Vaccines

Experience

No experience has been shared yet.